The EVERY Company Quadruples OvoPro Capacity After Orders Surge 550% in Four Months
The EVERY Company has agreed a manufacturing expansion with Bulgarian pharmaceutical group Huvepharma that will quadruple production capacity for OvoPro, its precision-fermented ovalbumin protein, following a period of sharp commercial growth. The agreement tasks Huvepharma’s manufacturing subsidiary, Biovet AD, with scaling output at its fermentation sites in Bulgaria, which hold over 9 million litres of installed fermentation capacity. According to the company, EVERY recorded annual orders in the first four …